Motility of human colorectal cancer cells is promoted by H1047R kinase mutation of PI3K p110-alpha

被引：0
|
作者：
Wan, Guanghua [1 ]
Ongchin, Melanie [2 ]
Hand, Essence [1 ]
Rajput, Ashwani [1 ]
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Univ Buffalo SUNY, Buffalo, NY USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-470
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
470
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The H1047R point mutation in p110 alpha of PI3K decrease Bcl2 expression in human colon cancer HCT116 cells
    Wan, Guanghua
    Rajput, Ashwani
    [J]. CANCER RESEARCH, 2015, 75
  • [2] Colon Cancer Tumorigenesis Initiated by the H1047R Mutant PI3K
    Yueh, Alexander E.
    Payne, Susan N.
    Leystra, Alyssa A.
    Van De Hey, Dana R.
    Foley, Tyler M.
    Pasch, Cheri A.
    Clipson, Linda
    Matkowskyj, Kristina A.
    Deming, Dustin A.
    [J]. PLOS ONE, 2016, 11 (02):
  • [3] DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110α (H1047R)
    Liu, Jia-li
    Gao, Guo-rui
    Zhang, Xi
    Cao, Su-fen
    Guo, Chen-liang
    Wang, Xiang
    Tong, Lin-jiang
    Ding, Jian
    Duan, Wen-hu
    Meng, Ling-hua
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 348 (03): : 432 - 441
  • [4] The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells
    G Wan
    C Pehlke
    R Pepermans
    JL Cannon
    D Lidke
    A Rajput
    [J]. Cell Death Discovery, 1
  • [5] The H1047R point mutation in p110 alpha changes the morphology of human colon HCT116 cancer cells
    Wan, G.
    Pehlke, C.
    Pepermans, R.
    Cannon, J. L.
    Lidke, D.
    Rajput, A.
    [J]. CELL DEATH DISCOVERY, 2015, 1
  • [6] Structural Perturbations due to Mutation (H1047R) in Phosphoinositide-3-kinase (PI3Kα) and Its Involvement in Oncogenesis: An in Silico Insight
    Sharma, Jatin
    Bhardwaj, Vijay
    Purohit, Rituraj
    [J]. ACS OMEGA, 2019, 4 (14): : 15815 - 15823
  • [7] Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein
    Ketcham, John M.
    Harwood, Stephen J.
    Aranda, Ruth
    Aloiau, Athenea N.
    Bobek, Briana M.
    Briere, David M.
    Burns, Aaron C.
    Haatveit, Kersti Caddell
    Calinisan, Andrew
    Clarine, Jeffery
    Elliott, Adam
    Engstrom, Lars D.
    Gunn, Robin J.
    Ivetac, Anthony
    Jones, Benjamin
    Kuehler, Jon
    Lawson, J. David
    Nguyen, Natalie
    Parker, Cody
    Pearson, Kelly E.
    Rahbaek, Lisa
    Saechao, Barbara
    Wang, Xiaolun
    Waters, Anna
    Waters, Laura
    Watkins, Ashlee H.
    Olson, Peter
    Smith, Christopher R.
    Christensen, James G.
    Marx, Matthew A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4936 - 4949
  • [8] A new class of selective inhibitors of the p110-alpha isoform of PI3K as cancer drugs
    Denny, William
    Kendall, Jackie
    Rewcastle, Gordon
    Shepherd, Peter
    Flanagan, Jack
    Baguley, Bruce
    Kestell, Phil
    Giddens, Anna
    Tsang, Sophia
    Marshall, Andrew
    [J]. CANCER RESEARCH, 2009, 69
  • [9] Discovery of benzoxazepin PI3K inhibitors and optimization of p110-alpha selectivity
    Ndubaku, Chudi O.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [10] Human HER2 and PI3K H1047R cooperate to promote mammary tumorigenesis in vivo
    Hanker, Ariella B.
    Kuba, Maria G.
    Sanchez, Violeta
    Sutton, Cammie R.
    Pfefferle, Adam
    Balko, Justin M.
    Perou, Charles M.
    Cook, Rebecca S.
    Arteaga, Carlos L.
    [J]. CANCER RESEARCH, 2012, 72
12345